VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,186 | -7.2% | 18,793 | +41.6% | 0.02% | -34.6% |
| Q2 2023 | $87,469 | +171.1% | 13,273 | +179.4% | 0.03% | +160.0% |
| Q1 2023 | $32,259 | -85.5% | 4,751 | -84.2% | 0.01% | -86.5% |
| Q4 2022 | $222,594 | +10.2% | 30,121 | +47.4% | 0.07% | -26.0% |
| Q3 2022 | $202,000 | +242.4% | 20,433 | +277.4% | 0.10% | +170.3% |
| Q2 2022 | $59,000 | -58.5% | 5,414 | -57.1% | 0.04% | -47.9% |
| Q1 2022 | $142,000 | -52.2% | 12,631 | -33.3% | 0.07% | -48.6% |
| Q4 2021 | $297,000 | +81.1% | 18,949 | +98.0% | 0.14% | +31.4% |
| Q3 2021 | $164,000 | -25.1% | 9,570 | -6.0% | 0.10% | -23.9% |
| Q2 2021 | $219,000 | – | 10,182 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |